Plavix sales help BMS into profit

January 29, 2009
Sales and Marketing BMS, Plavix

Strong fourth quarter sales of its blockbuster blood thinner Plavix have helped Bristol-Myers Squibb back into the black. Net earnings …

Novartis launches Extavia in Europe

January 28, 2009
Sales and Marketing Extavia, MS

Novartis has launched its new multiple sclerosis injection Extavia in Europe and hopes this will lay the groundwork for an …

Who owns the brand?

January 27, 2009
Sales and Marketing branding, marketing

For all of us in brand marketing, it is worth remembering that creating and nurturing a brand can be like …

Roche and Novo Nordisk to restrict distribution

January 27, 2009
Manufacturing and Production supply chain

Roche and Novo Nordisk are the latest companies to cut the number of wholesalers allowed to supply their medicines to …

Pfizer unveils $68 billion takeover of Wyeth

January 26, 2009
Sales and Marketing MA, Pfizer

Pfizer has unveiled a deal to acquire Wyeth for $68 billion, creating a new giant in pharmaceuticals, biotech, vaccines, consumer …

Green light for kidney cancer drugs in Wales

January 26, 2009
Sales and Marketing NHS, par, rcc

Kidney cancer patients in Wales are to gain access to the four new drugs that are still denied on the …

Pfizer to make merger bid for Wyeth

January 26, 2009
Sales and Marketing MA, Pfizer

Pfizer looks set to make a multi-billion dollar takeover of fellow US pharma company Wyeth.The world's largest pharma company, Pfizer …

GSK hopeful of NICE approval for Tyverb

January 26, 2009
Sales and Marketing Cancer, GSK, breast cancer

NICE could be poised to reverse its rejection of GSK's breast cancer treatment Tyverb, the pharma company has said.NICE rejected …

Working Life: Sam Knivett

January 23, 2009
Business Services, Research and Development Pfizer, UK, WL, Working Life, careers, compliance, drug safety

How did you find your way into your current role?From the age of 11 I wanted to be a farmer. …

Merck Serono’s multiple sclerosis drug on track for filing

January 23, 2009
Research and Development, Sales and Marketing MS, Merck Serono

Cladribine, a new oral treatment for multiple sclerosis is on track for a mid-2009 filing after the release of encouraging …

Prescription charges abolished for cancer patients

January 23, 2009
Sales and Marketing NHS, hc

Cancer patients in England can now apply for free NHS prescriptions, potentially saving individuals up to £100 each year. The …

FDA finalises transgenic animals guide

January 23, 2009
Research and Development, Sales and Marketing FDA, US, reg

The route map for companies wishing to sell medicines made in genetically-engineered animals has been drawn up by the FDA. …

Personal health budgets on the horizon

January 22, 2009
Sales and Marketing NHS, hc

Patients will have greater choice and more control over the kind of healthcare they receive under new government measures. The …

ReNeuron’s ground-breaking stem cell trial approved

January 22, 2009
Research and Development ReNeuron, stem cell

 UK biotech ReNeuron has been given the go-ahead for a ground-breaking stem cell clinical trial.The phase I trial of its …

Engaging with the NHS in 2009

January 22, 2009
Sales and Marketing NHS, event, healthcare, priorities

Delegates arriving at the conference to the strains of Jeff Wayne's War of the Worlds must have wondered whether they …

UK Biotech: time for bold and affirmative action

January 22, 2009
Research and Development, Sales and Marketing BTG, Chris Collins, Christopher Evans, Neuropharm, Plethora, UK, biotech, pharma, strategy

Biotech leaders in the UK say the cash-stricken industry has reached ‘breaking point’, and have made an unprecedented plea for …

Xoma slashes manufacturing to cut costs

January 22, 2009
Manufacturing and Production Xoma

Xoma has instigated a major cull of its workforce, with 144 jobs to go in a move that will cut …

Teva and Lonza join forces in biosimilars

January 21, 2009
Sales and Marketing biosimilars, generics

Teva, the world's largest generics manufacturer, has teamed up with manufacturing specialist Lonza to exploit the market for biosimilar medicines. …

The Gateway to Local Adoption Series

Latest content